Managed Services July 27, 2018 The Economics of Rare Disease and Implications for Payer Contract Strategy 3 Minute Read Rare diseases affect 30 million people in the United States, which roughly equates to 10% of the population. In 2017, 40% of the novel drugs approved by the FDA...
